Drug Approval | November 21, 2022
Aurobindo Pharma receives 10 observations for Unit IX
The company had responded to the agency and carried out the required corrective actions.
The company had responded to the agency and carried out the required corrective actions.
Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data
The approval further strengthens the Potassium Chloride franchise for the company.
The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Cadila Pharmaceuticals was felicitated during the plenary session of the 21st International Leprosy Congress
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
